- Investing Ideas
- Global Pharmaceuticals & Biotech Undervalued based on future growth
Global Pharmaceuticals & Biotech Undervalued based on future growth
Results
41
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
41 companies
TG Therapeutics
Market Cap: US$6.9b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$48.74
7D
-2.0%
1Y
73.6%
Grifols
Market Cap: €5.9b
Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.
GRF
€9.86
7D
-3.1%
1Y
-21.1%
China Medical System Holdings
Market Cap: HK$28.5b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$11.82
7D
-4.9%
1Y
-12.4%
Organon
Market Cap: US$3.6b
Develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$13.72
7D
0.9%
1Y
45.3%
Hypera
Market Cap: R$15.1b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$21.51
7D
-0.4%
1Y
-5.7%
ADMA Biologics
Market Cap: US$2.1b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$9.47
7D
-4.3%
1Y
-44.3%
Hugel
Market Cap: ₩2.8t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩256,000.00
7D
-6.4%
1Y
-19.2%
Pharma Mar
Market Cap: €1.5b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€83.95
7D
7.1%
1Y
1.5%
Bora Pharmaceuticals
Market Cap: NT$52.1b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$409.00
7D
-2.0%
1Y
-47.8%
Square Pharmaceuticals
Market Cap: ৳194.3b
Manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳219.20
7D
-0.4%
1Y
-2.5%
Lotus Pharmaceutical
Market Cap: NT$47.4b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$180.50
7D
-4.0%
1Y
-10.0%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥8.7b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥15.93
7D
12.8%
1Y
-0.2%
Omeros
Market Cap: US$1.2b
A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.
OMER
US$17.19
7D
29.7%
1Y
289.8%
Luye Pharma Group
Market Cap: HK$8.2b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$2.05
7D
-3.8%
1Y
-46.1%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩37,400.00
7D
7.0%
1Y
8.4%
Shanghai Haohai Biological Technology
Market Cap: HK$7.8b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$16.75
7D
2.1%
1Y
-42.7%
Sihuan Pharmaceutical Holdings Group
Market Cap: HK$7.8b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China, the United States, and internationally.
460
HK$0.86
7D
-5.0%
1Y
-39.9%
Strides Pharma Science
Market Cap: ₹89.2b
A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.
STAR
₹967.80
7D
-3.6%
1Y
8.1%
SSY Group
Market Cap: HK$7.0b
An investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.41
7D
0.2%
1Y
-21.9%
China Shineway Pharmaceutical Group
Market Cap: HK$6.1b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.05
7D
-0.06%
1Y
-2.7%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$5.4b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals.
3613
HK$6.48
7D
-2.9%
1Y
-29.9%
Zevra Therapeutics
Market Cap: US$672.2m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.32
7D
-2.1%
1Y
20.0%
DongKook Pharmaceutical
Market Cap: ₩889.6b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩19,720.00
7D
2.2%
1Y
11.3%
Beximco Pharmaceuticals
Market Cap: ৳65.9b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally.
BXPHARMA
৳147.80
7D
1.4%
1Y
28.1%
Tong Ren Tang Technologies
Market Cap: HK$4.2b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$3.28
7D
-2.5%
1Y
-38.5%
Renata
Market Cap: ৳54.1b
Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh and Portugal.
RENATA
৳471.70
7D
-0.1%
1Y
-4.6%
Dong-A Socio Holdings
Market Cap: ₩616.5b
Engages in the pharmaceutical business in South Korea.
A000640
₩93,000.00
7D
4.5%
1Y
-13.2%
Viva Biotech Holdings
Market Cap: HK$3.1b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.51
7D
4.9%
1Y
-42.8%
Blau Farmacêutica
Market Cap: R$2.1b
A pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.
BLAU3
R$9.02
7D
3.3%
1Y
-3.3%
Medy-Tox
Market Cap: ₩501.2b
Operates as a biopharmaceutical company in South Korea.
A086900
₩76,900.00
7D
-3.6%
1Y
-36.6%
Fuji Pharma
Market Cap: JP¥48.3b
Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.
4554
JP¥1,851.00
7D
4.5%
1Y
27.7%
Jacobson Pharma
Market Cap: HK$2.1b
Through its subsidiaries, engages in the development, production, marketing, and sale of essential medicines and specialty drugs in Hong Kong, Mainland China, Macau, and internationally.
2633
HK$1.05
7D
-0.5%
1Y
-27.9%
Essex Bio-Technology
Market Cap: HK$1.3b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$2.35
7D
-0.6%
1Y
-60.0%
Daewon Pharmaceutical
Market Cap: ₩170.6b
A pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea.
A003220
₩7,960.00
7D
-2.5%
1Y
-40.2%
Daihan PharmaceuticalLtd
Market Cap: ₩157.0b
Engages in the manufacture and sale of therapeutic drugs in South Korea.
A023910
₩26,700.00
7D
-1.1%
1Y
-11.9%
Macrogen
Market Cap: ₩139.3b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩12,850.00
7D
4.3%
1Y
-19.3%